These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 1686562

  • 1. The effect of GR122311X, a bismuth compound with H2-antagonist activity, on 24-hour intragastric acidity.
    Prewett EJ, Nwokolo CU, Hudson M, Sawyerr AM, Fraser A, Pounder RE.
    Aliment Pharmacol Ther; 1991 Oct; 5(5):481-90. PubMed ID: 1686562
    [Abstract] [Full Text] [Related]

  • 2. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
    Lacey LF, Frazer NM, Keene ON, Smith JT.
    Eur J Clin Pharmacol; 1994 Oct; 47(2):177-80. PubMed ID: 7859806
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection.
    Ciociola AA, Webb DD, Heath A, Walsh JH.
    Aliment Pharmacol Ther; 1996 Dec; 10(6):905-12. PubMed ID: 8971287
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
    Stables R, Campbell CJ, Clayton NM, Clitherow JW, Grinham CJ, McColm AA, McLaren A, Trevethick MA.
    Aliment Pharmacol Ther; 1993 Jun; 7(3):237-46. PubMed ID: 8364129
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h.
    Lanzon-Miller S, Pounder RE, Chronos NA, Raymond F, Hamilton MR, Dalgleish D.
    Gut; 1988 Oct; 29(10):1364-9. PubMed ID: 2904394
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
    Nwokolo CU, Smith JT, Sawyerr AM, Pounder RE.
    Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of low doses of ranitidine on intragastric acidity in healthy men.
    Wyeth JW, Pounder RE, Sercombe JC, Snell CC.
    Aliment Pharmacol Ther; 1998 Mar; 12(3):255-61. PubMed ID: 9570260
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ranitidine bismuth citrate and aspirin-induced gastric mucosal injury.
    Hudson N, Murray FE, Cole AT, Turnbull GM, Lettis S, Hawkey CJ.
    Aliment Pharmacol Ther; 1993 Oct; 7(5):515-21. PubMed ID: 7904188
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.